GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 13.634
NA - Nord America 13.633
AS - Asia 9.999
SA - Sud America 1.625
AF - Africa 423
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 39.401
Nazione #
US - Stati Uniti d'America 13.348
RU - Federazione Russa 5.016
SG - Singapore 4.400
IT - Italia 2.715
CN - Cina 2.211
GB - Regno Unito 2.083
BR - Brasile 1.318
HK - Hong Kong 944
VN - Vietnam 884
DE - Germania 669
IE - Irlanda 654
FR - Francia 640
SE - Svezia 567
FI - Finlandia 505
KR - Corea 336
BD - Bangladesh 250
IN - India 196
NL - Olanda 144
UA - Ucraina 143
TR - Turchia 138
ID - Indonesia 132
ES - Italia 131
CA - Canada 129
AR - Argentina 103
JP - Giappone 96
MX - Messico 94
IQ - Iraq 75
NG - Nigeria 75
TG - Togo 72
PL - Polonia 69
ZA - Sudafrica 69
AU - Australia 67
AT - Austria 57
BJ - Benin 57
EC - Ecuador 55
PK - Pakistan 39
SA - Arabia Saudita 37
CH - Svizzera 35
BE - Belgio 34
CO - Colombia 31
UZ - Uzbekistan 31
MA - Marocco 30
MY - Malesia 29
CL - Cile 28
IR - Iran 27
EG - Egitto 26
PY - Paraguay 24
KE - Kenya 21
VE - Venezuela 20
PH - Filippine 19
TN - Tunisia 19
BO - Bolivia 18
DZ - Algeria 18
KZ - Kazakistan 17
CZ - Repubblica Ceca 16
AL - Albania 15
DK - Danimarca 14
HU - Ungheria 14
IL - Israele 14
JM - Giamaica 14
NP - Nepal 14
PE - Perù 14
PT - Portogallo 14
RO - Romania 14
HR - Croazia 12
JO - Giordania 12
UY - Uruguay 12
AZ - Azerbaigian 11
LT - Lituania 10
NZ - Nuova Zelanda 10
TH - Thailandia 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
GR - Grecia 9
MM - Myanmar 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
GE - Georgia 6
GH - Ghana 6
IS - Islanda 6
LK - Sri Lanka 6
OM - Oman 6
AO - Angola 5
CR - Costa Rica 5
EE - Estonia 5
LV - Lettonia 5
BH - Bahrain 4
BN - Brunei Darussalam 4
GD - Grenada 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
AM - Armenia 3
BB - Barbados 3
CG - Congo 3
CI - Costa d'Avorio 3
Totale 39.325
Città #
Singapore 2.254
Ashburn 1.848
Southend 1.591
Moscow 1.570
San Jose 1.495
Dallas 1.331
Chandler 1.055
Jacksonville 956
Hong Kong 925
Dublin 643
Woodbridge 552
Verona 547
Council Bluffs 482
Houston 444
Ann Arbor 431
The Dalles 407
Beijing 372
Ho Chi Minh City 323
New York 279
Los Angeles 241
Wilmington 220
Lawrence 215
Princeton 215
Milan 205
Hanoi 202
Rome 165
Helsinki 159
Munich 150
Buffalo 137
Jinan 135
Nanjing 133
Redondo Beach 130
São Paulo 120
London 113
Santa Clara 110
Shenyang 100
Sindelfingen 93
Jakarta 80
Chicago 76
Tianjin 73
Lomé 72
Abuja 68
Frankfurt am Main 65
Hebei 63
Lappeenranta 62
Bologna 61
Tokyo 61
Guangzhou 58
Cotonou 57
Seattle 56
Haikou 55
Changsha 53
Orem 53
Washington 52
Warsaw 51
Naples 48
Amsterdam 47
Columbus 46
Chennai 45
Hangzhou 44
Madrid 44
Nanchang 44
Redwood City 42
Atlanta 41
Rio de Janeiro 41
Phoenix 40
Brooklyn 39
Haiphong 39
Da Nang 38
Zhengzhou 38
Johannesburg 37
Toronto 37
Belo Horizonte 36
Montreal 36
Boardman 35
Jiaxing 34
Mexico City 33
Vienna 33
Nuremberg 32
Florence 31
Turin 30
Venice 30
Brasília 29
Brussels 29
Falls Church 29
Kent 29
Shanghai 29
Curitiba 28
Ningbo 28
Stockholm 28
Genoa 27
Manchester 27
Redmond 27
Tashkent 27
Boston 26
Istanbul 26
Esslingen am Neckar 25
Kuala Lumpur 25
Sydney 25
Baghdad 24
Totale 22.992
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 673
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 451
Il ruolo della vitamina D nella dermatite atopica 424
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 364
A systematic review of treatments for pityriasis lichenoides 339
A new instrument for the screening of psoriatic arthritis among psoriatic patients 334
Dietary supplements for lipedema 318
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 212
Advanced Glycation End Products in the Pathogenesis of Psoriasis 203
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 202
Gender perspective in the management of psoriasis 191
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 187
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 183
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 182
Heat urticaria: a revision of published cases with an update on classification and management 179
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 173
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 173
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 172
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 171
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 169
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 169
Polymorphisms, diet and nutrigenomics 167
Lebbra lepromatosa. 166
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 165
Acneiform eruption induced by cetuximab 164
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 163
Retention rate of systemic drugs in patients with chronic plaque psoriasis 163
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 162
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 162
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 161
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 161
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 160
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 159
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 159
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 158
Incidence of respiratory and allergic symptoms in Italian and immigrant children 157
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 157
Psoriasis, the liver, and the gastrointestinal tract 156
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 156
Impact of the COVID-19 pandemic on melanoma diagnosis 156
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. 155
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 155
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 153
Main nutritional deficiencies 153
Psoriasis and the metabolic syndrome 152
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 152
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 151
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 150
Impact of TNF-α antagonists on the quality of life in selected skin diseases 150
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 149
Complicanze dell'obesità: la cute 148
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 148
Squamous cell carcinoma arising in lupus vulgaris. 147
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 147
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 147
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 146
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 146
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 146
Aggiornamento sulla terapie biologiche della psoriasi 145
Targeting TNF-a in psoriasis and psoriatic arthritis. 145
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 144
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 143
Effects of secukinumab on serum adipocytokines: preliminary data 143
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 143
Attitude to treatment of patients with psoriasis attending SPA center 142
Vitamin D levels in patients with psoriasis with or without arthritis 142
Severe impairment of quality of life in Hailey-Hailey disease. 140
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 140
Image Gallery: Pyoderma gangrenosum of the penis. 140
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 139
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 139
Ki67/MART1 and p63/SOX10 Dual Immunohistochemistry Allows a Correct Interpretation of the Melanocytic Component in the Diagnosis of Pigmented Pilomatricoma 139
Pimecrolimus in dermatology: atopic dermatitis and beyond. 138
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 138
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 138
Chronic plaque psoriasis is associated with increased arterial stiffness 137
Considerations for Systemic Treatment of Psoriasis in Obese Patients 136
Vitamin D status in patients with chronic plaque psoriasis 135
Systemic therapy of psoriasis in diabetic patients 135
Advanced Glycation End Products and Psoriasis 134
Phenotypes of atopic dermatitis 134
The metabolic syndrome in psoriasis 134
Some considerations about the importance of alliance between patients and dermatologists in psoriasis 134
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 134
Diabetes and the Skin 133
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 132
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study 132
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 132
Psoriasi. Una guida per una migliore gestione del paziente. 132
Dermatite atopica. 132
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 131
Metabolic comorbidities and psoriasis. 131
The expectations of patients with psoriasis during an office consultation 131
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 130
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 128
Hyperuricaemia in patients with chronic plaque psoriasis. 128
Uncommon Non‑Infectious Annular Dermatoses 127
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 127
Usefulness of the Framingham risk score in patients with chronic psoriasis 127
Risk of Hospitalization and Death From COVID-19 Infection in Patients With Chronic Plaque Psoriasis Receiving a Biologic Treatment and Renal Transplant Recipients in Maintenance Immunosuppressive Treatment 127
Totale 16.907
Categoria #
all - tutte 142.351
article - articoli 138.079
book - libri 429
conference - conferenze 0
curatela - curatele 0
other - altro 200
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.643
Totale 284.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20256.581 386 349 230 1.037 360 299 414 308 941 466 582 1.209
2025/202618.779 1.418 925 1.662 2.672 4.371 1.123 1.780 1.209 1.392 993 537 697
Totale 39.834